BioSource’s Warrants for Stock Exercised
- Share via
BioSource International Inc., a Camarillo producer of immunological reagents and test kits used in biomedical research, reports that warrants to purchase 700,000 shares of its common stock were exercised last month for a total price of $932,000.
James Chamberlain, president and chief executive, said the purchases mean “practically all” of BioSource’s outstanding warrants have been exercised.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
